Genova purchased all assets of Metametrix and will continue to operate under both brands at this time. The combined entity will provide a broader range of testing services, as well as increase the breadth of support and resources dedicated to physicians and their patients.
"We share a mission of improving the health of patients worldwide by striving to be the best provider of comprehensive and innovative clinical laboratory services,” said J. Alexander Bralley, CEO of Metametrix. Bralley will continue working in a consulting capacity in the newly aligned organization, focusing on development of next-generation testing approaches and clinical education programs.
"Consolidating our companies significantly increases our global presence,” said Ted Hull, chairman and CEO of Genova Diagnostics. “Together, we serve over 9,000 healthcare practitioners annually throughout the United States and internationally in 45 countries with our 400 employees and three locations in Asheville, N.C., Duluth, Ga., and London, England. Our combined resources will allow us to expand investments in research & development, clinical trials, medical education and market expansion.”
Financial terms of the transaction were not disclosed.